Verastem Inc (NASDAQ: VSTM) kicked off on Monday, down -6.81% from the previous trading day, before settling in for the closing price of $5.73. Over the past 52 weeks, VSTM has traded in a range of $2.10-$14.22.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -47.66%. While this was happening, its average annual earnings per share was recorded 23.45%. With a float of $39.64 million, this company’s outstanding shares have now reached $40.26 million.
The extent of productivity of a business whose workforce counts for 73 workers is very important to gauge. In terms of profitability, gross margin is 99.83%, operating margin of -1132.14%, and the pretax margin is -924.01%.
Verastem Inc (VSTM) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Verastem Inc is 10.94%, while institutional ownership is 49.90%. The most recent insider transaction that took place on Jan 13 ’25, was worth 44,909. Before that another transaction happened on Jan 06 ’25, when Company’s Chief Financial Officer sold 6 for $6.94, making the entire transaction worth $42. This insider now owns 47,639 shares in total.
Verastem Inc (VSTM) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 23.45% per share during the next fiscal year.
Verastem Inc (NASDAQ: VSTM) Trading Performance Indicators
Take a look at Verastem Inc’s (VSTM) current performance indicators. Last quarter, stock had a quick ratio of 3.23. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 23.77.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.19, a number that is poised to hit -0.83 in the next quarter and is forecasted to reach -2.56 in one year’s time.
Technical Analysis of Verastem Inc (VSTM)
The latest stats from [Verastem Inc, VSTM] show that its last 5-days average volume of 1.47 million was inferior to 2.75 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 57.86%. Additionally, its Average True Range was 0.64.
During the past 100 days, Verastem Inc’s (VSTM) raw stochastic average was set at 60.98%, which indicates a significant increase from 49.54% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 190.44% in the past 14 days, which was higher than the 111.03% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.62, while its 200-day Moving Average is $5.06. Now, the first resistance to watch is $5.84. This is followed by the second major resistance level at $6.34. The third major resistance level sits at $6.66. If the price goes on to break the first support level at $5.02, it is likely to go to the next support level at $4.70. The third support level lies at $4.20 if the price breaches the second support level.
Verastem Inc (NASDAQ: VSTM) Key Stats
The company with the Market Capitalisation of 237.66 million has total of 44,507K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -87,370 K annual income. Company’s last quarter sales were recorded 10,000 K and last quarter income was -8,260 K.
